Cebion HCT Tablet 5/40/12.5 mg

Adult dose

This medication should be taken once daily, with or without food, and preferably at the same time each day (e.g., in the morning). The recommended dosing is as follows: - 5/20/12.5 mg: For patients whose blood pressure is not adequately controlled with Amlodipine/Olmesartan Medoxomil 5/20 mg combination therapy. - 5/40/12.5 mg: For patients whose blood pressure is not adequately controlled with Amlodipine/Olmesartan Medoxomil 5/40 mg.

Child dose

Safety and efficacy in pediatric patients under 18 years of age have not been established, hence dosing of this medication is not recommended.

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients who are allergic to any of the ingredients or related medications should not take this medication. Patients with severe hypotension, severe renal and liver dysfunction, or certain diseases such as unstable heart failure after acute myocardial infarction should not use this medication. Patients with reduced blood volume or electrolyte imbalances may experience hypotension when administered this medication, so careful monitoring is required. It is important for patients with impaired kidney function to undergo regular blood tests to monitor kidney function and electrolyte levels. This medication has blood pressure-lowering effects, so caution is needed as dizziness may occur while driving or operating machinery. During treatment, the skin may become more sensitive to sunlight, so sun protection should be ensured. The use of this medication is not recommended during breastfeeding, and nursing mothers should consider stopping breastfeeding or discontinuing the medication. The safety and efficacy of this medication have not been established in children under 18 years of age, so its use is not recommended. Elderly patients should begin at a low dose considering decreased liver, kidney, and heart function along with concurrent diseases, and use it with caution. In case of overdose, symptoms such as hypotension, palpitations, and bradycardia may occur, and immediate medical attention should be sought for appropriate treatment. This medication should be stored in a tightly closed container away from humidity, heat, and direct sunlight, and out of reach of children.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, mucosal pain in mouth/eyes, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities associated with cough + fever, yellowing of skin or eyes (jaundice), profound lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urinary changes.

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory infection
• nasopharyngitis
• urinary tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature.

Appearance

Pale yellow round film-coated tablet

Package unit

28 tablets (14 tablets/PTP × 2)